The study was conducted in accordance with the ethical principles of the Declaration of Helsinki and the nice Clinical Practice guidelines of the International Meeting on Harmonisation. The study was funded by Pfizer, and representatives of Pfizer designed the study, collected the data from the study centers, and performed the info analyses. All the authors had full access to all of the study data, interpreted the info, and collaborated on the writing of the manuscript.Effective immediately, this second contract builds upon the initial partnership and expands the reach of Sage’s leading contamination prevention products into marketplaces where they are not currently marketed. Related StoriesGenetic carrier screening: an interview with Don Hardison, CEO of Good Start GeneticsUsing integrated molecular pathology to manage incidental pancreatic cysts: an interview with Dr Ananya DasSurgical startup seeks funding to build virtual reality schooling libraryUnder the banner of ‘Partners in Prevention,’ the companies also intend to collaborate on a number of initiatives designed to minimize the risk of healthcare-associated infections . Collaborative efforts may include joint client education programs, co-sponsored events and other initiatives that improve patient care and reduce risk, important for both companies.